参考文献/References:
[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.DOI:10.3760/cma.j.cn115791-20210221-00095.
[2] Gold AE,MacLeod KM,Frier BM.Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia[J].Diabetes Care,1994,17(7):697-703.DOI:10.2337/diacare.17.7.697.
[3] American Diabetes Association.2.Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021[J].Diabetes Care,2021,44(Suppl 1):S15-S33.DOI:10.2337/dc21-S002.
[4] Leelarathna L,Little SA,Walkinshaw E,et al.Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial[J].Diabetes Care,2013,36(12):4063-4070.DOI:10.2337/dc13-1004.
[5] Clarke WL,Cox DJ,Gonder-Frederick LA,et al.Reduced awareness of hypoglycemia in adults with IDDM.A prospective study of hypoglycemic frequency and associated symptoms[J].Diabetes Care,1995,18(4):517-522.DOI:10.2337/diacare.18.4.517.
[6] Pedersen-Bjergaard U,Agerholm-Larsen B,Pramming S,et al.Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus[J].Lancet,2001,357(9264):1248-1253.DOI:10.1016/S0140-6736(00)04405-6.
[7] Ghandi K,Pieri B,Dornhorst A,et al.A comparison of validated methods used to assess impaired awareness of hypoglycaemia in type 1 diabetes: an observational study[J].Diabetes Ther,2021,12(1):441-451.DOI:10.1007/s13300-020-00965-0.
[8] Alkhatatbeh MJ,Abdalqader NA,Alqudah MAY.Impaired awareness of hypoglycaemia in insulin-treated type 2 diabetes mellitus[J].Curr Diabetes Rev,2019,15(5):407-413.DOI:10.2174/1573399814666180806144937.
[9] Peene B,D'Hooge D,Vandebrouck T,et al.Patient-reported frequency,awareness and patient-physician communication of hypoglycaemia in Belgium[J].Acta Clin Belg,2014,69(6):439-445.DOI:10.1179/2295333714Y.0000000050.
[10] 包頔,余杭青,程正楠,等.2型糖尿病患者低血糖感知受损现况及影响因素分析[J].天津护理,2021,29(1):33-37.DOI:10.3969/j.issn.1006-9143.2021.01.009.
[11] 包頔,余杭青,程正楠,等.老年糖尿病患者低血糖恐惧感发生情况及其影响因素研究[J].中国全科医学,2020,23(30):3775-3780.DOI:10.12114/j.issn.1007-9572.2020.00.484.
[12] Nwokolo M,Amiel SA,O'Daly O,et al.Impaired awareness of hypoglycemia disrupts blood flow to brain regions involved in arousal and decision making in type 1 diabetes[J].Diabetes Care,2019,42(11):2127-2135.DOI:10.2337/dc19-0337.
[13] Farrell CM,McCrimmon RJ.Clinical approaches to treat impaired awareness of hypoglycaemia[J].Ther Adv Endocrinol Metab,2021,12:1869597768.DOI:10.1177/20420188211000248.
[14] Jezequel C,de Kerdanet M,Girre MA.Hypoglycemia provoked by clandestine injections of insulin in the diabetic child[J].Ann Pediatr(Paris),1993,40(1):32-36.
[15] Long C,Dungan K.Hypoglycemia awareness and burden among hospitalized patients at high risk for hypoglycemia[J].J Diabetes Complications,2020,34(4):107521.DOI:10.1016/j.jdiacomp.2019.107521.
[16] Ma Y,Wang Q,Joe D,et al.Recurrent hypoglycemia inhibits the counterregulatory response by suppressing adrenal activity[J].J Clin Invest,2018,128(9):3866-3871.DOI:10.1172/JCI91921.
[17] Stantonyonge N,Sampedro F,Méndez J,et al.Structural gray and white matter differences in patients with type 1 diabetes and impaired awareness of hypoglycemia[J].J Clin Endocrinol Metab,2021,106(2):450-458.DOI:10.1210/clinem/dgaa832.
[18] Sampedro F,Stantonyonge N,Martinez-Horta S,et al.Increased cerebral FDG-PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia[J].J Neuroendocrinol,2021,33(1):e12910.DOI:10.1111/jne.12910.
[19] 中华医学会糖尿病学分会.中国持续葡萄糖监测临床应用指南(2017年版)[J].中华糖尿病杂志,2017,9(11):667-675.DOI:10.3760/cma.j.issn.1674-5809.2017.11.002.
[20] Blissett DB,Attvall S,Hellmund RA.Analysis estimating the potential cost Impact of utilizing flash glucose monitoring with optional alarms in Swedish adults with diabetes with impaired awareness of hypoglycaemia,using intensive insulin[J].Diabetes Ther,2021,12(8):2179-2193.DOI:10.1007/s13300-021-01099-7.
[21] Hvidberg A,Rasmussen MH,Christensen NJ,et al.Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients[J].Metabolism,1994,43(6):776-781.DOI:10.1016/0026-0495(94)90130-9.
[22] Watson JM,Sherwin RS,Deary IJ,et al.Dissociation of augmented physiological,hormonal and cognitive responses to hypoglycaemia with sustained caffeine use[J].Clin Sci(Lond),2003,104(4):447-454.
[23] de Galan BE,Schouwenberg BJ,Tack CJ,et al.Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes[J]. Neth J Med,2006,64(8):269-279.
[24] Farhat R,Su G,Sejling AS,et al.Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats[J].Diabetologia,2019,62(4):676-686.DOI:10.1007/s00125-018-4802-0.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(02):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(02):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(02):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(02):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(02):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]